| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Seres Therapeutics (MCRB) | Goldman Sachs/ BofA Merrill Lynch | $100.00 | n.a. | |||
| Sole Elite Group (SOLE) | Dawson James Securities | $33.00 | n.a. | |||
| Teladoc (TDOC) | J.P. Morgan/ Deutsche Bank Securities | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Ironshore (IRSH) | BofA Merrill Lynch/ UBS Investment Bank | $100.00 | 1/2 to 1 | |||
| MultiVir (MVIR) | RBC Capital Markets | 4.60 | $12.00 | $14.00 | $59.80 | n.a. |
| New Terms | ||||||
| DAVIDsTEA (DTEA) | Goldman Sachs/ J.P. Morgan | 5.10 | $14.00 | $16.00 | $76.50 | 3-Stars |
| EndoChoice (ECPM Holdings) (GI) | J.P. Morgan/ BofA Merrill Lynch/ William Blair/ Stifel | 6.25 | $15.00 | $17.00 | $100.00 | 2-Stars |
| Evolent Health (EVH) | J.P. Morgan/ Goldman Sachs | 10.00 | $14.00 | $16.00 | $150.00 | 3-Stars |
| PennTex Midstream Partners, LP (PTXP) | Citigroup/ Barclays/ RBC Capital Markets/ Tudor, Pickering, Holt | 11.25 | $19.00 | $21.00 | $225.00 | 2-Stars |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of May 25, 2015 | Manager(s) | Offered | Raised | Price | 5/29/15 | Change |
| None | ||||||
